Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

（Nilotinib）尼洛替尼

A powerful and precise second-generation tyrosine kinase inhibitor that can effectively treat patients with drug-resistant or intolerant chronic myelogenous leukemia.

Categories: Breast glands and blood, Oncology drugs

Share:

Health Classification

Let us work together to protect precious health

More